We are thrilled to announce that StrokeDx has successfully raised $5 million in Series Seed Prime funding to advance our groundbreaking #stroke technology!
✔ Round led by DigiTx Partners, with participation from Freeflow Ventures and other existing investors with domain expertise
✔ David J. Kim, M.D., Managing Director of DigiTx Partners, joins our board
✔ This investment will fund further clinical validation and expansion of our commercial efforts
StrokeDx is dedicated to developing advanced, portable, non-invasive cerebrovascular monitoring technology to improve stroke outcomes for millions of at-risk individuals. With this funding, we can enhance our early detection and rapid monitoring solutions, providing a scalable, equitable approach to healthcare accessibility.
“Stroke affects millions globally, leading to significant mortality and long-term disability. This funding enables us to scale our detection and monitoring solution, empowering physicians and their patients with an effective tool for point-of-care cerebrovascular monitoring. Early intervention can significantly reduce the impact of stroke, shifting the focus from treatment to prevention,” said Alex Ballatori, Co-Founder and CEO of StrokeDx.
“We believe in the potential of StrokeDx’s technology to change the diagnostic paradigm and ultimately improve outcomes for stroke patients. By providing accessible, advanced technology, we can reach millions of at-risk individuals, potentially saving countless lives and reducing the burden on healthcare systems around the world,” said David J. Kim, MD, Managing Director of DigiTx Partners.
Press Release: https://lnkd.in/gs8agwM2
#Stroke #NeuroTech #DigitalHealth #MedTech #HealthTech #MedicalInnovation #Healthcare #StrokeAwareness #Funding #VentureCapital #HealthEquity #StrokeDx
Senior Healthcare Leader, Innovator & Entrepreneur>Advise Medtech, Startups, Public Agencies on Translating Data into Evidence | Championed Market Launch & Growth of 100s of Products for Diverse Indication Areas
2moFantastic news and very important area for innovation, as stroke diagnosis remains one of the most critical and challenging aspects of modern medicine. Excited to learn more about your evgen strategy!